Status:
COMPLETED
The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Western Trauma Association
Novo Nordisk A/S
Conditions:
Traumatic Hemorrhage
Hemorrhagic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Trauma surgeons throughout the US have begun using recombinant activated factor VII (rFVIIa) to control severe hemorrhage following injury when traditional measures have failed. Despite promising resu...
Detailed Description
This is a prospective, multi-center case registry that seeks to combine the collective experience with the use of rFVIIa at UCSF/SFGH with other trauma centers. The study is being conducted under the ...
Eligibility Criteria
Inclusion
- Coagulopathy treated with rFVIIa
Exclusion
- none
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00328133
Start Date
June 1 2006
End Date
June 1 2011
Last Update
May 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco, San Francisco General Hospital
San Francisco, California, United States, 94110